Cover Image
市場調查報告書

單純皰疹病毒病:全球臨床實驗趨勢

Herpes Simplex Infections Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 235376
出版日期 內容資訊 英文 87 Pages
訂單完成後即時交付
價格
Back to Top
單純皰疹病毒病:全球臨床實驗趨勢 Herpes Simplex Infections Global Clinical Trials Review, H1, 2015
出版日期: 2015年05月27日 內容資訊: 英文 87 Pages
簡介

本報告提供單純皰疹病毒病相關臨床研究的最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,受驗者採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 單純皰疹病毒病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染疾病治療藥臨床實驗上單純皰疹病毒病的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病治療藥臨床實驗上單純皰疹病毒病的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

單純皰疹病毒病治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞 單純皰疹病毒病

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Novartis AG
    • CRA Holdings, Inc.
    • Maruho
    • Astellas Pharma Inc.
    • Santo Holding AG
    • Benchmark Research
    • Agenus, Inc.
    • Hammersmith Medicines Research Ltd.
    • Genocea Biosciences, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • University of Washington
    • The National Institute of Allergy and Infectious Diseases
    • National Center for Research Resources
    • University of Pittsburgh
    • French National Agency for Research on AIDS and Viral Hepatitis
    • National Eye Institute
    • U.S. Department of Veterans Affairs
    • University Health Network
    • Assistance Publique Hopitaux De Marseille
    • Blood Systems Research Institute

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2697CTIDB

GlobalData's clinical trial report, "Herpes Simplex Infections Global Clinical Trials Review, H1, 2015" provides an overview of Herpes Simplex Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Simplex Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Herpes Simplex Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Herpes Simplex Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Herpes Simplex Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Herpes Simplex Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Herpes Simplex Infections Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Herpes Simplex Infections
      • Apr 27, 2015: NanoViricides Discusses the Strong Effectiveness of Its Anti-Herpes Drug Candidates in a Lethal Animal Model of Dermal Herpes Infection
      • Apr 20, 2015: NanoViricides Reports that Its Topical Anti-Herpes Treatment Dramatically Improves Clinical Symptoms in an Animal Model
      • Apr 10, 2015: Admedus has high hopes for Herpes vaccine as dosing commences
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • CRA Holdings, Inc.
      • Clinical Trial Overview of CRA Holdings, Inc.
      • Maruho Co., Ltd.
      • Clinical Trial Overview of Maruho Co., Ltd.
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Santo Holding AG
      • Clinical Trial Overview of Santo Holding AG
      • Benchmark Research
      • Clinical Trial Overview of Benchmark Research
      • Agenus, Inc.
      • Clinical Trial Overview of Agenus, Inc.
      • Hammersmith Medicines Research Ltd.
      • Clinical Trial Overview of Hammersmith Medicines Research Ltd.
      • Genocea Biosciences, Inc.
      • Clinical Trial Overview of Genocea Biosciences, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • French National Agency for Research on AIDS and Viral Hepatitis
      • Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • Assistance Publique Hopitaux De Marseille
      • Clinical Trial Overview of Assistance Publique Hopitaux De Marseille
      • Blood Systems Research Institute
      • Clinical Trial Overview of Blood Systems Research Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials by Region, 2015*
  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Herpes Simplex Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Herpes Simplex Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Herpes Simplex Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Herpes Simplex Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Herpes Simplex Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Herpes Simplex Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Herpes Simplex Infections Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Herpes Simplex Infections Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Herpes Simplex Infections Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Herpes Simplex Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by CRA Holdings, Inc., 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Maruho Co., Ltd., 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Santo Holding AG, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Benchmark Research, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Agenus, Inc., 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hammersmith Medicines Research Ltd., 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Genocea Biosciences, Inc., 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Blood Systems Research Institute, 2015*

List of Figures

  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Herpes Simplex Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Herpes Simplex Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Herpes Simplex Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Herpes Simplex Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Herpes Simplex Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Herpes Simplex Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Herpes Simplex Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Herpes Simplex Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Herpes Simplex Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top